INVESTOR RELATIONS
press release – price-sensitive
30/09/2024
THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 202425/07/2024
JOINT VENTURE AGREEMENT SIGNED WITH EXOSOMICS S.P.A. FOR THE ESTABLISHMENT OF LONGEVITY BIOSCIENCE SRL18/07/2024
TURNOVER FOR THE FIRST HALF OF 2024 EQUAL TO 2.3 MILLION EUROS, AN INCREASE COMPARED TO THE SAME PERIOD IN 202306/05/2024
TURNOVER AS OF 31 MARCH 2024 EQUAL TO 1.1 MILLION EUROS, AN INCREASE OF 26.3% COMPARED TO THE SAME PERIOD IN 202330/04/2024
ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.06/04/2024
PUBLICATION OF NOTICE OF CALL FOR ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING